Intriguingly, enhanced HHV-6-specific T cell responses were observed in all HT patients, with a marked increase in the number of CD4+ T lymphocytes recognizing HHV-6 antigens, particularly the subset of polyfunctional CD4+ T cells secreting both IFN-γ and IL-2. The gene discussed is IFNG; the disease is hematocrit.